EXTON, PA--(Marketwired - April 24, 2013) - West Pharmaceutical Services, Inc. (NYSE: WST) confirmed today that it will release first quarter 2013 financial results before the market opens on Thursday, May 2, 2013 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 866-515-2911 (U.S.) or 617-399-5125 (International). The passcode is 14629585.
A live broadcast of the conference call will be available at the Company's web site, www.westpharma.com, in the "Investors" section. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast. Management will refer to a slide presentation during the call, which will be made available on the day of the call. To view the presentation, select "Presentations" in the "Investors" section of the Company's website. The presentation will be in "PDF" format and, if needed, the website includes a link to a free download of software that will enable viewing of the PDF presentation.
An online archive of the broadcast will be available at the site two hours after the live call and will be available through Thursday, May 9, 2013, by dialing 888-286-8010 (U.S.) or 617-801-6888 (International) and entering passcode 56474691.
West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability and safety of their products. Every day, West is leading the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched and growing knowledge base of relevant pharmaceutical product testing, development and packaging. Based in Exton, Pa., West supports its customers from sales, manufacturing, customer support and research and development locations in North and South America, Europe, Asia and Australia. Established in 1923, West's 2012 sales were $1.3 billion.